All News
|
Research Feature
When CBS’s 60 Minutes aired the compelling story of a Florida woman whose severe sickle cell disease symptoms were alleviated with a cutting edge gene therapy technique, people listened. A lot of them. The treatment happened at the National Institutes of Health, and since the showcasing of its dramatic success, NIH has been responding to scores of...
|
NHLBI in the Press
A study partly funded by NHLBI shows potential link between bad quality sleep and Alzheimer’s disease in Hispanics/Latinos.
|
NHLBI in the Press
In a study of over 25,000 people ages 17-93 years, researchers found that smoking just a few cigarettes a day is as harmful to the lungs as smoking a pack or more per day.
|
NHLBI in the Press
Atherosclerotic plaques, a fatty buildup that over time hardens and narrows the arteries, contain an abundance of immune cells, according to a study published in Nature Medicine.
|
NHLBI in the Press
Researchers at the NIH have developed a new and improved viral vector—a virus-based vehicle that delivers therapeutic genes—for use in gene therapy for sickle cell disease.
|
NHLBI in the Press
A study by NIH researchers found that a high-performing, low-field MRI system could improve lung and cardiac imaging.
|
NHLBI in the Press
A study, published in the New England Journal of Medicine, found that African-Americans with poorly controlled asthma responded differently to commonly used treatments.
|
NHLBI in the Press
During Sickle Cell Awareness Month, Alabamian Lynndrick Holmes, 29, shared his experience of being free of the sickle cell disease two years after receiving genetic treatment as part of an NIH clinical trial that might hold the key to a cure of this disease.
|
NHLBI in the Press
A study partly funded by the NHLBI found that young adults who use electronic cigarettes are especially influenced by flavors, which motivate them to start vaping, and, later, to continue using them, leading to addiction.
|
NHLBI in the Press
Researchers are reporting that CAR T-cell therapy, an emerging type of immunotherapy that uses a patient’s own cells to treat certain blood cancers such as lymphoma and leukemia, might be used to treat heart disease.
|
NHLBI in the Press
Our immune cells use a gene assembly process called V(D)J recombination to mix the genetic code and generate new antibodies that conquer pathogens and threaten our health.
|
NHLBI in the Press
Researchers have developed tiny nanocapsules that show promise as an alternative way to deliver gene-editing tools for treating disease.
|
NHLBI in the Press
Researchers have identified new cellular processes controlling the formation of the body’s lymphatic valves.
|
NHLBI in the Press
Study shows promising approach to reducing plaque buildup in arteries in mice
|
NHLBI in the Press
A new study has found that long-term use of e-cigarettes, or vaping, can trigger the same biological changes seen in cigarette smokers who develop emphysema.
|
NHLBI in the Press
The mechanical properties of immune cells in the lungs may influence their response when fighting infection, according to a study published in Nature.
|
NHLBI in the Press
A single use of nicotine-free electronic cigarettes can damage a person’s blood vessels, according to a study published in Radiology.
|
NHLBI in the Press
During a heart attack, dying heart muscle cells can send signals to neighboring cells. This process is known as hypoxic ischemic injury, which adds insult to injury.
|
NHLBI in the Press
Researchers validated a computer model that reliably predicted where irregular heartbeats persist.
|
NHLBI in the Press
Scientists have viewed transplantation of so-called induced pluripotent stem cells (iPSCs), which can be reprogrammed into virtually any tissue or organ in the body, as a key event in the regenerative medicine revolution.
|
NHLBI in the Press
Measuring daytime and nighttime blood pressure outside of a clinic setting may be a better predictor of heart disease and stroke risk among African Americans than measurements taken at the clinic, a new study shows.